Cambridge Investment Research Advisors’s Paramount Global 5.75% Series A Mandatory Convertible Preferred Stock PARAP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-24,257
Closed -$431K 3324
2023
Q3
$431K Sell
24,257
-2,565
-10% -$54.3K ﹤0.01% 2211
2023
Q2
$608K Sell
26,822
-3,357
-11% -$87.3K ﹤0.01% 1981
2023
Q1
$904K Sell
30,179
-230
-0.8% -$7.03K ﹤0.01% 1637
2022
Q4
$753K Buy
30,409
+4,987
+20% +$144K ﹤0.01% 1710
2022
Q3
$786K Sell
25,422
-2,335
-8% -$89.3K ﹤0.01% 1637
2022
Q2
$1.1M Buy
27,757
+1,390
+5% +$63.9K 0.01% 1418
2022
Q1
$1.47M Buy
26,367
+1,585
+6% +$89.5K 0.01% 1325
2021
Q4
$1.25M Buy
+24,782
New +$1.43M 0.01% 1435

Other funds holding PARAP

Cambridge Investment Research Advisors's PARAP Position: Q4 2023 in Review

Cambridge Investment Research Advisors sold out of Paramount Global 5.75% Series A Mandatory Convertible Preferred Stock (PARAP) in Q4 2023, closing a stake of 24,257 shares — an estimated $431K sold.

Cambridge Investment Research Advisors first reported a position in PARAP in Q4 2021 and held it in 8 quarters. The position peaked at $1.47M in Q1 2022. 47 funds tracked by Wall St. Rank hold PARAP as of Q4 2023.

  • Cambridge Investment Research Advisors reported no remaining Paramount Global 5.75% Series A Mandatory Convertible Preferred Stock position as of Q4 2023 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 24,257 Paramount Global 5.75% Series A Mandatory Convertible Preferred Stock shares in Q4 2023, an estimated $431K.
  • Cambridge Investment Research Advisors first reported a position in Paramount Global 5.75% Series A Mandatory Convertible Preferred Stock in Q4 2021 and held it in 8 quarters.
  • Cambridge Investment Research Advisors's Paramount Global 5.75% Series A Mandatory Convertible Preferred Stock position peaked at $1.47M in Q1 2022.
  • 47 funds tracked by Wall St. Rank held Paramount Global 5.75% Series A Mandatory Convertible Preferred Stock as of Q4 2023.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2023, filed 9 Feb 2024.